Philip Gregory
Director/Board Member bei American Society of Gene & Cell Therapy
Vermögen: 2 Mio $ am 31.03.2024
Profil
Philip D.
Gregory is currently the Director at the American Society of Gene & Cell Therapy.
Previously, he held the position of Chief Scientific Officer & Senior VP-Research at Sangamo Therapeutics, Inc. from 2014 to 2015.
He also served as the Senior Vice President-Operations at Flextronics Components Group.
From 2015 to 2021, Dr. Gregory was the Chief Scientific Officer at bluebird bio, Inc. Additionally, he held the position of Chief Scientific Officer at 2seventy Bio, Inc. Dr. Gregory completed his undergraduate studies at The University of Sheffield and obtained a doctorate degree from Keble College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
2SEVENTY BIO, INC.
0,60% | 08.01.2024 | 310 280 ( 0,60% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Philip Gregory
Unternehmen | Position | Beginn |
---|---|---|
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Director/Board Member | 02.05.2019 |
Ehemalige bekannte Positionen von Philip Gregory
Unternehmen | Position | Ende |
---|---|---|
BLUEBIRD BIO, INC. | Chief Tech/Sci/R&D Officer | 04.11.2021 |
SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 29.05.2015 |
Flextronics Components Group
Flextronics Components Group SemiconductorsElectronic Technology International DisplayWorks, Inc. used to manufacture display components. It was a manufacturer and designer of liquid crystal displays, modules and assemblies. The company's Sales offices were located in United States, Europe, Hong Kong, Singapore and China. International DisplayWorks was headquartered in Roseville, CA. | Chief Operating Officer | 30.11.2006 |
2SEVENTY BIO, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Philip Gregory
The University of Sheffield | Undergraduate Degree |
Keble College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
BLUEBIRD BIO, INC. | Health Technology |
2SEVENTY BIO, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Flextronics Components Group
Flextronics Components Group SemiconductorsElectronic Technology International DisplayWorks, Inc. used to manufacture display components. It was a manufacturer and designer of liquid crystal displays, modules and assemblies. The company's Sales offices were located in United States, Europe, Hong Kong, Singapore and China. International DisplayWorks was headquartered in Roseville, CA. | Electronic Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |